featured
Sorafenib+Capecitabine Compared With Placebo+Capecitabine in Locally Advanced or Metastatic HER2− Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer